| Year |
Citation |
Score |
| 2003 |
Winnard P, Cashon RE, Sidell BD, Vayda ME. Isolation, characterization and nucleotide sequence of the muscle isoforms of creatine kinase from the Antarctic teleost Chaenocephalus aceratus. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 134: 651-67. PMID 12670791 DOI: 10.1016/S1096-4959(03)00025-3 |
0.393 |
|
| 2002 |
Winnard P, Sidell BD, Vayda ME. Teleost introns are characterized by a high A+T content. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 133: 155-61. PMID 12381377 DOI: 10.1016/S1096-4959(02)00104-5 |
0.392 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Li C, Winnard P, Bhujwalla ZM. Facile synthesis of 1-(acetic acid)-4,7,10-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraaza-cyclododecane: a reactive precursor chelating agent. Tetrahedron Letters. 50: 2929-2931. PMID 20161259 DOI: 10.1016/J.TETLET.2009.03.198 |
0.19 |
|
| 2011 |
Penet M, Winnard PT, Marik R, Nimmagadda S, Pomper MG, Bhujwalla ZM. Abstract 5276: Exploration of the cachectic phenotype Cancer Research. 71: 5276-5276. DOI: 10.1158/1538-7445.Am2011-5276 |
0.183 |
|
| 2007 |
Gilad AA, Winnard PT, van Zijl PC, Bulte JW. Developing MR reporter genes: promises and pitfalls. Nmr in Biomedicine. 20: 275-90. PMID 17451181 DOI: 10.1002/nbm.1134 |
0.153 |
|
| 2013 |
Chen Z, Penet MP, Krishnamachary B, Li C, Winnard PT, Pomper MG, Bhujwalla ZM. Abstract 4345: PSMA-targeted theranostic nanoplex combining TRAIL gene cDNA and prodrug enzyme delivery for prostate cancer treatment. Cancer Research. 73: 4345-4345. DOI: 10.1158/1538-7445.Am2013-4345 |
0.133 |
|
| 2008 |
Winnard PT, Botlagunta M, Kluth JB, Mukadam S, Krishnamachary B, Vesuna F, Raman V. Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model. Cancer Gene Therapy. 15: 645-54. PMID 18551145 DOI: 10.1038/cgt.2008.39 |
0.12 |
|
| 2006 |
Duriseti S, Winnard PT, Mironchik Y, Vesuna F, Raman A, Raman V. HOXA5 regulates hMLH1 expression in breast cancer cells. Neoplasia (New York, N.Y.). 8: 250-8. PMID 16756717 DOI: 10.1593/neo.05766 |
0.116 |
|
| 2016 |
Winnard PT, Bharti SK, Penet MF, Marik R, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZM. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. Cancer Research. 76: 1441-50. PMID 26719527 DOI: 10.1158/0008-5472.CAN-15-1740 |
0.113 |
|
| 1989 |
Winnard PT, Esmon CT, Laue TM. The molecular weight and oligomerization of rabbit thrombomodulin as assessed by sedimentation equilibrium Archives of Biochemistry and Biophysics. 269: 339-344. PMID 2537060 DOI: 10.1016/0003-9861(89)90115-X |
0.103 |
|
| 2007 |
Gilad AA, McMahon MT, Walczak P, Winnard PT, Raman V, van Laarhoven HW, Skoglund CM, Bulte JW, van Zijl PC. Artificial reporter gene providing MRI contrast based on proton exchange. Nature Biotechnology. 25: 217-9. PMID 17259977 DOI: 10.1038/nbt1277 |
0.102 |
|
| 2007 |
Winnard PT, Kluth JB, Kato Y, Artemov D, Raman V. Development of novel chimeric transmembrane proteins for multimodality imaging of cancer cells. Cancer Biology & Therapy. 6: 1889-99. PMID 18059163 |
0.102 |
|
| 2015 |
Xie M, Vesuna F, Botlagunta M, Bol GM, Irving A, Bergman Y, Hosmane RS, Kato Y, Winnard PT, Raman V. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Oncotarget. 6: 29901-13. PMID 26337079 DOI: 10.18632/oncotarget.4898 |
0.099 |
|
| 2010 |
Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, Winnard PT, Raman V, Ebina M, Nukiwa T, Yamamoto M. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis. 31: 1833-43. PMID 20513672 DOI: 10.1093/Carcin/Bgq105 |
0.098 |
|
| 2006 |
Li C, Winnard PT, Takagi T, Artemov D, Bhujwalla ZM. Multimodal image-guided enzyme/prodrug cancer therapy. Journal of the American Chemical Society. 128: 15072-3. PMID 17117842 DOI: 10.1021/ja066199i |
0.095 |
|
| 2008 |
Li C, Wildes F, Winnard P, Artemov D, Penet MF, Bhujwalla ZM. Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/prodrug cancer therapy. Journal of Medicinal Chemistry. 51: 3572-82. PMID 18517259 DOI: 10.1021/jm800288h |
0.095 |
|
| 2010 |
Li C, Penet MF, Wildes F, Takagi T, Chen Z, Winnard PT, Artemov D, Bhujwalla ZM. Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. Acs Nano. 4: 6707-16. PMID 20958072 DOI: 10.1021/nn102187v |
0.094 |
|
| 1995 |
Virzi F, Winnard P, Fogarasi M, Sano T, Smith CL, Cantor CR, Rusckowski M, Hnatowich DJ. Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc Bioconjugate Chemistry. 6: 139-144. PMID 7711101 |
0.092 |
|
| 2018 |
Tantravedi S, Vesuna F, Winnard PT, Martin A, Lim M, Eberhart CG, Berlinicke C, Raabe E, van Diest PJ, Raman V. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33. Translational Oncology. 12: 96-105. PMID 30292066 DOI: 10.1016/J.Tranon.2018.09.002 |
0.091 |
|
| 2008 |
Glunde K, Shah T, Winnard PT, Raman V, Takagi T, Vesuna F, Artemov D, Bhujwalla ZM. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Research. 68: 172-80. PMID 18172309 DOI: 10.1158/0008-5472.CAN-07-2678 |
0.091 |
|
| 2012 |
Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM. PSMA-targeted theranostic nanoplex for prostate cancer therapy. Acs Nano. 6: 7752-62. PMID 22866897 DOI: 10.1021/Nn301725W |
0.089 |
|
| 2004 |
Winnard P, Raman V. Real time non-invasive imaging of receptor-ligand interactions in vivo. Journal of Cellular Biochemistry. 90: 454-63. PMID 14523979 DOI: 10.1002/jcb.10616 |
0.089 |
|
| 1997 |
Hnatowich DJ, Virzi F, Fogarasi M, Rusckowski M, Winnard P. Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies? Nuclear Medicine and Biology. 21: 1035-44. PMID 9234361 DOI: 10.1016/0969-8051(94)90175-9 |
0.085 |
|
| 2023 |
Winnard PT, Morsberger L, Yonescu R, Jiang L, Zou YS, Raman V. Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations. Cancers. 15. PMID 36900209 DOI: 10.3390/cancers15051420 |
0.085 |
|
| 2010 |
Chen Z, Penet M, Nimmagadda S, Li C, Ray S, Winnard PT, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM. Abstract 5481: Theranostic imaging of metastatic prostate cancer Cancer Research. 70: 5481-5481. DOI: 10.1158/1538-7445.Am10-5481 |
0.082 |
|
| 2020 |
Winnard PT, Vesuna F, Muthukumar S, Raman V. Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity. Plos One. 15: e0242384. PMID 33196681 DOI: 10.1371/journal.pone.0242384 |
0.082 |
|
| 2014 |
Winnard PT, Challa R, Bhujwalla ZM, Raman V. Direct facile screening of recombinant DNA vector constructs. Analytical Biochemistry. 450: 1-3. PMID 24393695 DOI: 10.1016/j.ab.2013.12.034 |
0.079 |
|
| 2010 |
Shah T, Wildes F, Penet MF, Winnard PT, Glunde K, Artemov D, Ackerstaff E, Gimi B, Kakkad S, Raman V, Bhujwalla ZM. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. Nmr in Biomedicine. 23: 633-42. PMID 20623626 DOI: 10.1002/nbm.1510 |
0.079 |
|
| 2011 |
Penet MF, Winnard PT, Jacobs MA, Bhujwalla ZM. Understanding cancer-induced cachexia: imaging the flame and its fuel. Current Opinion in Supportive and Palliative Care. 5: 327-33. PMID 21986909 DOI: 10.1097/SPC.0b013e32834c49ba |
0.078 |
|
| 2009 |
Chen CW, Blackwell TR, Naphas R, Winnard PT, Raman V, Glunde K, Chen Y. Development of needle-based microendoscopy for fluorescence molecular imaging of breast tumor models Journal of Innovative Optical Health Sciences. 2: 343-352. DOI: 10.1142/S1793545809000747 |
0.077 |
|
| 2011 |
Jiang L, Chughtai K, Artemov D, Winnard P, Raman V, Bhujwalla ZM, Heeren RMA, Glunde K. Abstract 5272: Combined magnetic resonance spectroscopic imaging and MALDI mass spectrometric imaging to characterize breast cancer lipid metabolism Cancer Research. 71: 5272-5272. DOI: 10.1158/1538-7445.Am2011-5272 |
0.076 |
|
| 2006 |
Winnard PT, Kluth JB, Raman V. Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia (New York, N.Y.). 8: 796-806. PMID 17032496 DOI: 10.1593/neo.06304 |
0.075 |
|
| 2017 |
Winnard PT, Zhang C, Vesuna F, Kang JW, Garry J, Dasari RR, Barman I, Raman V. Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes. Oncotarget. PMID 28145887 DOI: 10.18632/Oncotarget.14865 |
0.073 |
|
| 2017 |
Dore-Savard L, Chen Z, Winnard PT, Krishnamachary B, Raman V, Black ME, Bhujwalla ZM. Delayed Progression of Lung Metastases Following Delivery of a Prodrug-activating Enzyme. Anticancer Research. 37: 2195-2200. PMID 28476782 DOI: 10.21873/anticanres.11554 |
0.072 |
|
| 2011 |
Botlagunta M, Krishnamachary B, Vesuna F, Winnard PT, Bol GM, Patel AH, Raman V. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. Plos One. 6: e17563. PMID 21448281 DOI: 10.1371/journal.pone.0017563 |
0.071 |
|
| 1997 |
Winnard P, Chang F, Rusckowski M, Mardirossian G, Hnatowich D. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA Nuclear Medicine and Biology. 24: 425-432. DOI: 10.1016/S0969-8051(97)80010-8 |
0.07 |
|
| 2012 |
Penet MF, Chen Z, Li C, Winnard PT, Bhujwalla ZM. Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage. Drug Delivery and Translational Research. 2: 22-30. PMID 23646292 DOI: 10.1007/s13346-011-0052-0 |
0.069 |
|
| 2006 |
Raman V, Artemov D, Pathak AP, Winnard PT, McNutt S, Yudina A, Bogdanov A, Bhujwalla ZM. Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Research. 66: 9929-36. PMID 17047055 DOI: 10.1158/0008-5472.CAN-06-0886 |
0.069 |
|
| 2012 |
Jiang L, Greenwood TR, Artemov D, Raman V, Winnard PT, Heeren RM, Bhujwalla ZM, Glunde K. Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models. Neoplasia (New York, N.Y.). 14: 732-41. PMID 22952426 DOI: 10.1593/Neo.12858 |
0.067 |
|
| 2011 |
Chen Z, Penet M, Nimmagadda S, Li C, Ray S, Winnard PT, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM. Abstract 3629: Theranostic imaging of metastatic prostate cancer Cancer Research. 71: 3629-3629. DOI: 10.1158/1538-7445.Am2011-3629 |
0.067 |
|
| 2005 |
Mironchik Y, Winnard PT, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Research. 65: 10801-9. PMID 16322226 DOI: 10.1158/0008-5472.CAN-05-0712 |
0.066 |
|
| 2008 |
Li C, Penet MF, Winnard P, Artemov D, Bhujwalla ZM. Image-guided enzyme/prodrug cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 515-22. PMID 18223227 DOI: 10.1158/1078-0432.CCR-07-1837 |
0.066 |
|
| 2022 |
Vesuna F, Akhrymuk I, Smith A, Winnard PT, Lin SC, Panny L, Scharpf R, Kehn-Hall K, Raman V. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2. Frontiers in Microbiology. 13: 959577. PMID 36090095 DOI: 10.3389/fmicb.2022.959577 |
0.063 |
|
| 2022 |
Vesuna F, Akhrymuk I, Smith A, Winnard PT, Lin SC, Scharpf R, Kehn-Hall K, Raman V. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 35262079 DOI: 10.1101/2022.02.28.482334 |
0.063 |
|
| 2009 |
Koskimaki JE, Karagiannis ED, Rosca EV, Vesuna F, Winnard PT, Raman V, Bhujwalla ZM, Popel AS. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia (New York, N.Y.). 11: 1285-91. PMID 20019836 DOI: 10.1593/Neo.09620 |
0.06 |
|
| 2023 |
Roux A, Winnard PT, Van Voss MH, Muller L, Jackson SN, Hoffer B, Woods AS, Raman V. MALDI-MSI of lipids in a model of breast cancer brain metastasis provides a surrogate measure of ischemia/hypoxia. Molecular and Cellular Biochemistry. PMID 36884151 DOI: 10.1007/s11010-023-04685-4 |
0.059 |
|
| 2005 |
Winnard P, Mironchik Y, Raman V. Robust expression of transgenes in MCF-7 breast cancer cells is expression vector-dependent. Biotechniques. 37: 370, 372, 374. PMID 15470890 DOI: 10.2144/04373BM06 |
0.058 |
|
| 2017 |
Tantravedi S, Vesuna F, Winnard PT, Van Voss MRH, Van Diest PJ, Raman V. Role of DDX3 in the pathogenesis of inflammatory bowel disease. Oncotarget. 8: 115280-115289. PMID 29383159 DOI: 10.18632/oncotarget.23323 |
0.057 |
|
| 1994 |
Hnatowich DJ, Winnard P, Virzi F, Niemeyer C, Dalan AB, Sano T, Smith CL, Cantor CR, Rusckowski M. AMPLIFICATION OF RADIOACTIVITY USING COMPLEMENTARY DNA CONJUGATES Journal of Immunotherapy. 16: 158. DOI: 10.1097/00002371-199408000-00048 |
0.057 |
|
| 2013 |
Chughtai K, Jiang L, Post H, Winnard PT, Greenwood TR, Raman V, Bhujwalla ZM, Heeren RM, Glunde K. Mass spectrometric imaging of red fluorescent protein in breast tumor xenografts. Journal of the American Society For Mass Spectrometry. 24: 711-7. PMID 23184411 DOI: 10.1007/S13361-012-0503-Y |
0.056 |
|
| 2013 |
Jiang L, Greenwood TR, van Hove ER, Chughtai K, Raman V, Winnard PT, Heeren RM, Artemov D, Glunde K. Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model. Nmr in Biomedicine. 26: 285-98. PMID 22945331 DOI: 10.1002/Nbm.2846 |
0.051 |
|
| 2008 |
Winnard PT, Pathak AP, Dhara S, Cho SY, Raman V, Pomper MG. Molecular imaging of metastatic potential. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 96S-112S. PMID 18523068 DOI: 10.2967/Jnumed.107.045948 |
0.047 |
|
| 2010 |
Botlagunta M, Winnard PT, Raman V. Neoplastic transformation of breast epithelial cells by genotoxic stress. Bmc Cancer. 10: 343. PMID 20591176 DOI: 10.1186/1471-2407-10-343 |
0.046 |
|
| 2020 |
Winnard PT, Bharti SK, Sharma RK, Krishnamachary B, Mironchik Y, Penet MF, Goggins MG, Maitra A, Kamel I, Horton KM, Jacobs MA, Bhujwalla ZM. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle. PMID 33006443 DOI: 10.1002/jcsm.12621 |
0.045 |
|
| 2012 |
Zhang H, Wong CC, Wei H, Gilkes DM, Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B, Winnard PT, Raman V, Zhen L, Mitzner WA, Sukumar S, Semenza GL. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 31: 1757-70. PMID 21860410 DOI: 10.1038/Onc.2011.365 |
0.044 |
|
| 2006 |
Vesuna F, Winnard P, Glackin C, Raman V. Twist overexpression promotes chromosomal instability in the breast cancer cell line MCF-7. Cancer Genetics and Cytogenetics. 167: 189-91. PMID 16737925 DOI: 10.1016/J.CANCERGENCYTO.2006.01.014 |
0.044 |
|
| 2005 |
Vesuna F, Winnard P, Raman V. Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase. Analytical Biochemistry. 342: 345-7. PMID 15950916 DOI: 10.1016/J.AB.2005.04.047 |
0.043 |
|
| 2018 |
Zhang C, Winnard PT, Dasari S, Kominsky SL, Doucet M, Jayaraman S, Raman V, Barman I. Label-free Raman spectroscopy provides early determination and precise localization of breast cancer-colonized bone alterations. Chemical Science. 9: 743-753. PMID 29629144 DOI: 10.1039/C7Sc02905E |
0.041 |
|
| 2006 |
Winnard P, Glackin C, Raman V. Stable integration of an empty vector in MCF-7 cells greatly alters the karyotype. Cancer Genetics and Cytogenetics. 164: 174-6. PMID 16434326 DOI: 10.1016/J.CANCERGENCYTO.2005.07.021 |
0.041 |
|
| 2005 |
Stasinopoulos IA, Mironchik Y, Raman A, Wildes F, Winnard P, Raman V. HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. The Journal of Biological Chemistry. 280: 2294-9. PMID 15545268 DOI: 10.1074/jbc.M411018200 |
0.037 |
|
| 1994 |
Winnard P, Virzi F, Fogarasi M, Rusckowski M, Hnatowicn DJ. RADIOLABELING OP SINOLE-STRANDED DHA WITH TC99M AND IN111 Journal of Immunotherapy. 16: 149. DOI: 10.1097/00002371-199408000-00014 |
0.037 |
|
| 2010 |
Chen Y, Yuan S, Wierwille J, Naphas R, Li Q, Blackwell TR, Winnard PT, Raman V, Glunde K. Integrated optical coherence tomography (OCT) and fluorescence laminar optical tomography (FLOT) Ieee Journal On Selected Topics in Quantum Electronics. 16: 755-766. DOI: 10.1109/Jstqe.2009.2037723 |
0.036 |
|
| 2020 |
Winnard PT, Vesuna F, Raman V. Targeting host DEAD-box RNA helicase DDX3X for treating viral infections. Antiviral Research. 104994. PMID 33301755 DOI: 10.1016/j.antiviral.2020.104994 |
0.034 |
|
| 2008 |
Winnard PT, Sukumar S. A PET rat model for assessing the effectiveness of new chemotherapies. Cancer Biology & Therapy. 7: 538-9. PMID 18627116 DOI: 10.4161/Cbt.7.4.5642 |
0.03 |
|
| 2010 |
Chen Y, Yuan S, Wierwille J, Chen C, Blackwell TR, Winnard PT, Raman V, Glunde K. Integrated Optical Coherence Tomography (OCT) and Fluorescence Laminar Optical Tomography (FLOT) for Depth-resolved Subsurface Cancer Imaging Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2010.Bsud9 |
0.029 |
|
| 2009 |
Wong J, Artemov D, Tryggestad E, Winnard P. Combining X-ray and Optical 3D Imaging to Guide Focal Irradiation of Molecular Targets in Mice International Journal of Radiation Oncology*Biology*Physics. 75: S42-S43. DOI: 10.1016/j.ijrobp.2009.07.118 |
0.024 |
|
| Hide low-probability matches. |